5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial

医学 主动脉瓣置换术 狭窄 阀门更换 主动脉瓣狭窄 外科 主动脉瓣 随机对照试验 心脏病学 内科学
作者
Michael J. Mack,Martin B. Leon,Craig R. Smith,D. Craig Miller,Jeffrey W. Moses,E. Murat Tuzcu,John G. Webb,Pamela S. Douglas,William N. Anderson,Eugene H. Blackstone,Susheel Kodali,Raj Makkar,Gregory P. Fontana,Samir Kapadia,Joseph E. Bavaria,Rebecca T. Hahn,Vinod H. Thourani,Vasilis Babaliaros,Augusto D. Pichard,Howard C. Herrmann
出处
期刊:The Lancet [Elsevier BV]
卷期号:385 (9986): 2477-2484 被引量:1730
标识
DOI:10.1016/s0140-6736(15)60308-7
摘要

Background The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that mortality at 1 year, 2 years, and 3 years is much the same with transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) for high-risk patients with aortic stenosis. We report here the 5-year outcomes. Methods We did this randomised controlled trial at 25 hospitals, in Canada (two), Germany (one), and the USA (23). We used a computer-generated randomisation sequence to randomly assign high-risk patients with severe aortic stenosis to either SAVR or TAVR with a balloon-expandable bovine pericardial tissue valve by either a transfemoral or transapical approach. Patients and their treating physicians were not masked to treatment allocation. The primary outcome of the trial was all-cause mortality in the intention-to-treat population at 1 year, we present here predefined outcomes at 5 years. The study is registered with ClinicalTrials.gov, number NCT00530894. Findings We screened 3105 patients, of whom 699 were enrolled (348 assigned to TAVR, 351 assigned to SAVR). Overall mean Society of Thoracic Surgeons Predicted Risk of Mortality score was 11·7%. At 5 years, risk of death was 67·8% in the TAVR group compared with 62·4% in the SAVR group (hazard ratio 1·04, 95% CI 0·86–1·24; p=0·76). We recorded no structural valve deterioration requiring surgical valve replacement in either group. Moderate or severe aortic regurgitation occurred in 40 (14%) of 280 patients in the TAVR group and two (1%) of 228 in the SAVR group (p<0·0001), and was associated with increased 5-year risk of mortality in the TAVR group (72·4% for moderate or severe aortic regurgitation vs 56·6% for those with mild aortic regurgitation or less; p=0·003). Interpretation Our findings show that TAVR as an alternative to surgery for patients with high surgical risk results in similar clinical outcomes. Funding Edwards Lifesciences.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Mia123完成签到,获得积分10
1秒前
蜘蛛侠完成签到,获得积分10
5秒前
雪山大地发布了新的文献求助10
5秒前
咚咚大王完成签到 ,获得积分10
5秒前
博士完成签到 ,获得积分10
6秒前
几几完成签到,获得积分10
7秒前
cheng完成签到 ,获得积分10
8秒前
HJJHJH的应助被科研通管家采纳,获得30
9秒前
Owen的应助被科研通管家采纳,获得10
9秒前
长泽梓完成签到 ,获得积分20
10秒前
yli130发布了新的社区帖子
10秒前
SilentLight完成签到,获得积分10
11秒前
勤劳的夏天完成签到,获得积分10
13秒前
fantasy的应助被369ninja采纳,获得10
13秒前
16秒前
布曲完成签到 ,获得积分10
16秒前
19秒前
HQxiaohuan完成签到 ,获得积分10
20秒前
蓝精灵完成签到 ,获得积分10
20秒前
haralee完成签到 ,获得积分10
23秒前
Rui完成签到 ,获得积分10
24秒前
AKira完成签到 ,获得积分10
26秒前
Auster完成签到,获得积分10
27秒前
雪山大地发布了新的文献求助10
28秒前
小皮完成签到,获得积分10
28秒前
风中星月完成签到 ,获得积分10
29秒前
MM完成签到 ,获得积分10
30秒前
Auster发布了新的文献求助10
30秒前
savesunshine1022完成签到,获得积分10
31秒前
fantasy的应助被369ninja采纳,获得10
31秒前
小小吴完成签到,获得积分10
33秒前
科研通AI6.2的应助被小皮采纳,获得10
33秒前
水文小白完成签到,获得积分10
38秒前
一一完成签到 ,获得积分10
38秒前
Xueyu完成签到,获得积分10
41秒前
满意的平凡完成签到,获得积分10
41秒前
Rice完成签到,获得积分10
41秒前
沭阳检验医师完成签到,获得积分0
44秒前
钟原完成签到 ,获得积分10
47秒前
mtxh完成签到 ,获得积分10
49秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166550
求助须知:如何正确求助?哪些是违规求助? 9559535
关于积分的说明 21750720
捐赠科研通 7757357
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553523
邀请新用户注册赠送积分活动 2473904